COMPANY PROFILE / #3505
CoSyne Therapeutics
London, United KingdomVenture Capital-Backed
OVERVIEW
Operator of an AI-powered drug discovery company designed to accelerate the development of precision medicines for brain diseases. The company utilizes polymathic artificial intelligence and vertically integrated research processes to identify and develop therapeutic candidates, enabling healthcare providers to treat patients with underserved neurological conditions and brain cancer more effectively.
已融资12.99
最新估值27.52
员工数16
成立年份2021
公司概况
- Companies
- CoSyne Therapeutics
- Description
- Operator of an AI-powered drug discovery company designed to accelerate the development of precision medicines for brain diseases. The company utilizes polymathic artificial intelligence and vertically integrated research processes to identify and develop therapeutic candidates, enabling healthcare providers to treat patients with underserved neurological conditions and brain cancer more effectively.
- Website
- www.cosyne.com
- HQ Location
- London, United Kingdom
- Year Founded
- 2021
- Keywords
- ai in healthcare, biotechnology research, brain cancer treatment, drug discovery firm, drug discovery tech, neurological disease, precision medicine, small molecule
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 12.99
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 01-Jan-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 27.52
- Last Known Valuation Date
- 08-Aug-2024
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 42.82
- Valuation Estimate Growth Rate
- 55.60%
- Active Investors
- Amino Collective, Arc Ventures (United States), Backed, Frame Shift Bio-Incubator, Imperial Enterprise Lab, Innovate UK, Jonathan Milner, Meltwind Advisory, Phoenix Court, Start Codon, Valhalla Ventures
- # Active Investors
- 11
- Acquirers
- —
团队与联系人
- Employees
- 16
- Employee Growth %
- -36.00%
- Employee History
- 2026: 16, 2025: 25, 2024: 25, 2023: 17, 2022: 11
- Primary Contact
- Louwai Muhammed
- Primary Contact Title
- Co-Founder, Chief Executive Officer and Board Member
- Primary Contact Email
- louwai@cosyne.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 1.74x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 68
- Majestic Referring Domains
- 48
- SimilarWeb Unique Visitors
- 117
- SimilarWeb Unique Visitors Change
- 28
- SimilarWeb Growth Rate
- 0.00%
- SimilarWeb Growth Rate Percentile
- 9
- Success Probability Over Time – 1 Year
- 19%
- Success Probability Over Time – 3 Year
- 39%
- Success Probability Over Time – 5 Year
- 46%
记录来源：public.companies · 原始序号 #3505 · 所有字段均按数据库原值展示。